230 related articles for article (PubMed ID: 11716158)
1. Endocrine complications of thalassemia.
Tiosano D; Hochberg Z
J Endocrinol Invest; 2001 Oct; 24(9):716-23. PubMed ID: 11716158
[TBL] [Abstract][Full Text] [Related]
2. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
3. [Severe chronic anemia and endocrine disorders in children].
Hauschild M; Theintz G
Rev Med Suisse; 2007 Apr; 3(107):988-91. PubMed ID: 17526372
[TBL] [Abstract][Full Text] [Related]
4. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
Kattamis CA; Kattamis AC
Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
[No Abstract] [Full Text] [Related]
5. Advances in the recognition and treatment of endocrine complications in children with chronic illness.
Zeitler PS; Travers S; Kappy MS
Adv Pediatr; 1999; 46():101-49. PubMed ID: 10645463
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
De Sanctis V; Eleftheriou A; Malaventura C;
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
[TBL] [Abstract][Full Text] [Related]
7. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia.
Tan KA; Lum SH; Yahya A; Krishnan S; Jalaludin MY; Lee WS
Singapore Med J; 2019 Jun; 60(6):303-308. PubMed ID: 30556093
[TBL] [Abstract][Full Text] [Related]
9. The Thalassemia center of Antalya State Hospital: 15 years of experience (1994 to 2008).
Canatan D
J Pediatr Hematol Oncol; 2013 Jan; 35(1):24-7. PubMed ID: 23128337
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients.
Merchant RH; Shirodkar A; Ahmed J
Indian J Pediatr; 2011 Jun; 78(6):679-83. PubMed ID: 21234716
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and metabolic disorders in β-thalassemiamajor patients.
Saffari F; Mahyar A; Jalilolgadr S
Caspian J Intern Med; 2012; 3(3):466-72. PubMed ID: 24009916
[TBL] [Abstract][Full Text] [Related]
12. Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children.
Högler W; Baumann U; Kelly D
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):313-21. PubMed ID: 22064631
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine disorders in diabetes mellitus].
Okazaki R; Toriumi M; Tanaka K
Nihon Rinsho; 1997 Oct; 55 Suppl():667-72. PubMed ID: 9392179
[No Abstract] [Full Text] [Related]
14. Growth and endocrine function in thalassemia major in childhood and adolescence.
Delvecchio M; Cavallo L
J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539
[TBL] [Abstract][Full Text] [Related]
15. [Growth and endocrine function in major thalassemia].
Pérignon F; Brauner R; Souberbielle JC; de Montalembert M; Girot R
Arch Fr Pediatr; 1993 Oct; 50(8):657-63. PubMed ID: 8002739
[TBL] [Abstract][Full Text] [Related]
16. Endocrine gland abnormalities in thalassemia major: a brief review.
Mohammadian S; Bazrafshan HR; Sadeghi-Nejad A
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):957-64. PubMed ID: 14513870
[TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of growth retardation and pubertal disturbances in thalassemia.
Chatterjee R; Bajoria R
Ann N Y Acad Sci; 2010 Aug; 1202():100-14. PubMed ID: 20712780
[TBL] [Abstract][Full Text] [Related]
18. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
19. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
Kurtoglu AU; Kurtoglu E; Temizkan AK
Endokrynol Pol; 2012; 63(4):260-3. PubMed ID: 22933160
[TBL] [Abstract][Full Text] [Related]
20. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
